OGDHL
protein-codingoxoglutarate dehydrogenase L, the group of Oxoglutarate dehydrogenase family
Gene summary
The protein encoded by this gene is similar to oxoglutarate dehydrogenase (OGDH) of the OGDH complex, which degrades glucose and glutamate. This gene encodes several isoforms, including some that appear to localize to mitochondria. The encoded protein down-regulates the AKT signaling cascade and can suppress the growth of cervical cancer cells. [provided by RefSeq, Dec 2016]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~27.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859221
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0859221
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0859221
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859221
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Audiologic/Otolaryngologic
Rationale: Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to OGDHL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018245.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 2 | 16 | 6 | 25 | |
| missense | 1 | 2 | 178 | 10 | 1 | 192 |
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 2 | 6 | 8 | |||
| Total | 2 | 7 | 187 | 26 | 7 | 229 |
Highest pathogenic variant AF is 0.00002107999
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060715.2 | 22 | MANE Select | |
| Ensembl | ENSP00000363216.4 | 22 | MANE Select | |
| RefSeq | NP_001137468.1 | 21 | Standard | |
| RefSeq | NP_001137469.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Citrate cycle (TCA cycle) - Homo sapiens (human)
- Tryptophan metabolism - Homo sapiens (human)
- Lysine degradation - Homo sapiens (human)
- Lysine metabolism
- TCA cycle
Biological Process
- glycolytic process
- tricarboxylic acid cycle
Molecular Function
- oxoglutarate dehydrogenase (succinyl-transferring) activity
- protein binding
- thiamine pyrophosphate binding
- metal ion binding
Cellular Component
- mitochondrion
- mitochondrial matrix
- oxoglutarate dehydrogenase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000374103
- Coding exons
- 22
- Length
- 27737
- Individuals with no LoFs
- 125656
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 92
- Defined
- 125748
- p
- 0.000366
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.497 | 610 | 646 | 0.945 | 0.0000415 | 6649 |
| Missense (PolyPhen) | 209 | 227.95 | 0.91688 | 2224 | ||
| Synonymous | -0.00647 | 261 | 261 | 1.00 | 0.0000170 | 1963 |
| Loss of Function | 3.29 | 23 | 47.5 | 0.484 | 0.00000212 | 544 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00061 | 0.00060 | rare |
| South Asian | 0.00033 | 0.00033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- LoFtool
- 0.0661
- RVIS EVS
- -0.54
- RVIS percentile EVS
- 20.03
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.600
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |